145 related articles for article (PubMed ID: 37528690)
1. Retrospective neuropathological diagnosis of TDP-43 proteinopathies: Factors affecting immunoreactivity of phosphorylated TDP-43 in fixed post-mortem brain tissue.
Robinson AC; Davidson YS; Minshull J; Lally I; Walker L; Mann DMA; Roncaroli F
Neuropathology; 2024 Apr; 44(2):173-179. PubMed ID: 37528690
[No Abstract] [Full Text] [Related]
2. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
[TBL] [Abstract][Full Text] [Related]
3. Molecular dissection of TDP-43 proteinopathies.
Hasegawa M; Nonaka T; Tsuji H; Tamaoka A; Yamashita M; Kametani F; Yoshida M; Arai T; Akiyama H
J Mol Neurosci; 2011 Nov; 45(3):480-5. PubMed ID: 21678031
[TBL] [Abstract][Full Text] [Related]
4. Degenerator tau/TDP-43: rise of the machines.
Nestor PJ
J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):945. PubMed ID: 23503648
[No Abstract] [Full Text] [Related]
5. Lack of limbic-predominant age-related TDP-43 encephalopathy (LATE) neuropathological changes in aged macaques with memory impairment.
Darricau M; Canron MH; Bosc M; Arotçarena ML; Quang ML; Dehay B; Bezard E; Planche V
Neurobiol Aging; 2021 Nov; 107():53-56. PubMed ID: 34384992
[TBL] [Abstract][Full Text] [Related]
6. New terminology for a common TDP-43 proteinopathy.
Kurucu H; Spires-Jones T; Smith C
Lancet Neurol; 2019 Aug; 18(8):714-715. PubMed ID: 31202672
[No Abstract] [Full Text] [Related]
7. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.
Nelson PT; Dickson DW; Trojanowski JQ; Jack CR; Boyle PA; Arfanakis K; Rademakers R; Alafuzoff I; Attems J; Brayne C; Coyle-Gilchrist ITS; Chui HC; Fardo DW; Flanagan ME; Halliday G; Hokkanen SRK; Hunter S; Jicha GA; Katsumata Y; Kawas CH; Keene CD; Kovacs GG; Kukull WA; Levey AI; Makkinejad N; Montine TJ; Murayama S; Murray ME; Nag S; Rissman RA; Seeley WW; Sperling RA; White CL; Yu L; Schneider JA
Brain; 2019 Jun; 142(6):1503-1527. PubMed ID: 31039256
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice.
Medina DX; Orr ME; Oddo S
Neurobiol Aging; 2014 Jan; 35(1):79-87. PubMed ID: 23954172
[TBL] [Abstract][Full Text] [Related]
9. The phosphatase calcineurin regulates pathological TDP-43 phosphorylation.
Liachko NF; Saxton AD; McMillan PJ; Strovas TJ; Currey HN; Taylor LM; Wheeler JM; Oblak AL; Ghetti B; Montine TJ; Keene CD; Raskind MA; Bird TD; Kraemer BC
Acta Neuropathol; 2016 Oct; 132(4):545-61. PubMed ID: 27473149
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43.
King A; Maekawa S; Bodi I; Troakes C; Al-Sarraj S
Neuropathology; 2011 Jun; 31(3):239-49. PubMed ID: 21118398
[TBL] [Abstract][Full Text] [Related]
11. Autopsy of an Elderly Man With Incidentally Diagnosed TDP-43 Proteinopathy.
Hata Y; Yoshida K; Nishida N
Alzheimer Dis Assoc Disord; 2018; 32(2):158-161. PubMed ID: 29278558
[No Abstract] [Full Text] [Related]
12. Traumatic brain injury causes frontotemporal dementia and TDP-43 proteolysis.
Wang HK; Lee YC; Huang CY; Liliang PC; Lu K; Chen HJ; Li YC; Tsai KJ
Neuroscience; 2015 Aug; 300():94-103. PubMed ID: 25982564
[TBL] [Abstract][Full Text] [Related]
13. Foix-Chavany-Marie syndrome due to type E TDP43 pathology.
Clark CN; Quaegebeur A; Nirmalananthan N; MacKinnon AD; Revesz T; Holton JL; Bridges LR; Pereira AC
Neuropathol Appl Neurobiol; 2020 Apr; 46(3):292-295. PubMed ID: 31520433
[No Abstract] [Full Text] [Related]
14. Survival in the pre-senile dementia frontotemporal lobar degeneration with TDP-43 proteinopathy: effects of genetic, demographic and neuropathological variables.
Armstrong RA
Folia Neuropathol; 2016; 54(2):137-48. PubMed ID: 27543771
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and mis-metabolism of the neuropathological signature protein TDP-43.
Huang CC; Bose JK; Majumder P; Lee KH; Huang JT; Huang JK; Shen CK
J Cell Sci; 2014 Jul; 127(Pt 14):3024-38. PubMed ID: 24860144
[TBL] [Abstract][Full Text] [Related]
16. TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43.
Gendron TF; Rademakers R; Petrucelli L
J Alzheimers Dis; 2013; 33 Suppl 1(Suppl 1):S35-45. PubMed ID: 22751173
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies.
Neumann M; Kwong LK; Lee EB; Kremmer E; Flatley A; Xu Y; Forman MS; Troost D; Kretzschmar HA; Trojanowski JQ; Lee VM
Acta Neuropathol; 2009 Feb; 117(2):137-49. PubMed ID: 19125255
[TBL] [Abstract][Full Text] [Related]
18. Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins.
Zeballos C MA; Moore HJ; Smith TJ; Powell JE; Ahsan NS; Zhang S; Gaj T
Nat Commun; 2023 Oct; 14(1):6492. PubMed ID: 37838698
[TBL] [Abstract][Full Text] [Related]
19. Precision diagnosis and staging of TDP-43 proteinopathies: harnessing the power of artificial intelligence.
Hickman RA; Scholz SW
Brain; 2023 Jul; 146(7):2666-2668. PubMed ID: 37224516
[TBL] [Abstract][Full Text] [Related]
20. [Neuropathology of TDP-43 proteinopathy].
Akiyama H; Hasegawa M
Brain Nerve; 2013 Dec; 65(12):1477-89. PubMed ID: 24323933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
